Statement Of Changes In Equity [Abstract]

ERYTECH Pharma S.A. - Filing #2813524

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	228,000 EUR	—	228,000 EUR	—	—	53 797 EUR	—	—	—	—	53 797 EUR	—	73 300 EUR	—	—	73 300 EUR	—
Other comprehensive income	235,000 EUR	EUR	—	422,000 EUR	—	187,000 EUR	—	—	68,000 EUR	—	528,000 EUR	460,000 EUR	—	381,000 EUR	400,000 EUR	—	—	19,000 EUR
Comprehensive income	235,000 EUR	228,000 EUR	— EUR	194,000 EUR	— EUR	187,000 EUR	53 797 EUR	— EUR	68,000 EUR	— EUR	528,000 EUR	54 257 EUR	— EUR	72 919 EUR	400,000 EUR	— EUR	73 300 EUR	19,000 EUR
Increase (decrease) through other changes, equity	—	—	—	—	—	—	—	—	195,000 EUR	—	—	195,000 EUR	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	447,000 EUR	—	—	447,000 EUR	—	—	—	—	1 323 EUR	—	—	1 323 EUR	—	1 179 EUR	—	—	—	1 179 EUR